These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Human or animal homograft: could they have a future as a biological scaffold for engineered heart valves? Dainese L; Biglioli P J Cardiovasc Surg (Torino); 2010 Jun; 51(3):449-56. PubMed ID: 20523298 [TBL] [Abstract][Full Text] [Related]
31. Application of stem cells for cardiovascular grafts tissue engineering. Wu K; Liu YL; Cui B; Han Z Transpl Immunol; 2006 Jun; 16(1):1-7. PubMed ID: 16701169 [TBL] [Abstract][Full Text] [Related]
32. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110 [TBL] [Abstract][Full Text] [Related]
33. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701 [TBL] [Abstract][Full Text] [Related]
34. Stem cells: new cell source for myocardial constructs tissue engineering. Wu KH; Cui B; Yu CT; Liu YL Med Hypotheses; 2006; 67(6):1326-9. PubMed ID: 16814940 [TBL] [Abstract][Full Text] [Related]
35. Cardiac tissue engineering: current state and perspectives. Chiu LL; Iyer RK; Reis LA; Nunes SS; Radisic M Front Biosci (Landmark Ed); 2012 Jan; 17(4):1533-50. PubMed ID: 22201819 [TBL] [Abstract][Full Text] [Related]